Early prediction of cisplatin nephrotoxicity in head and neck cancer patients - an evaluation with urinary biomarkers

U. V. Saleena, K. Nalini, K. Gopalakrishna, R. Prabhu, B. M. Vadhiraja, M. S. Athiyamaan, Asha Kamath, Vidyasagar S Mamidipudi

Research output: Contribution to journalArticlepeer-review


Background: Nephrotoxic Acute Kidney Injury (AKI) is a common condition associated with considerable morbidity and mortality. Acute exposure to potentially nephrotoxic drugs requires early appraisal of the extent of renal injury to determine the need for specific interventions. Hence this study was designed to evaluate two urinary biomarkers for the early diagnosis of AKI due to cisplatin chemotherapy, including Neutrophil gelatinase-associated lipocalin (uNGAL) and Cystatin C (uCysC). Methods: Urinary biomarker levels in cisplatin treated cancer patients were estimated before and at 2hrs, 6hrs, 12hrs, 24hrs and 48hrs after cisplatin administration. Diagnostic performances of biomarkers were studied by ROC analysis with AUC and predictive values. Results: uNGAL was identified as the earlier biomarker of AKI induced by cisplatin as it detected kidney injury as early as 2hrs after the exposure of nephrotoxic drug with an AUC of 0.8, which is 46hrs before the elevation of serum creatinine. uCysC detected AKI 6hrs after cisplatin administration with AUC 0.73. Conclusion: Indication of AKI by biomarker elevations can provide an early warning signal which may have implications in therapy by either stopping the nephrotoxic drug or reducing its dose or even by substituting it with a less nephrotoxic one. The research in this direction should focus on evolving rapid procedures with an eventual point-of-care test for urinary biomarker determinations that will transform the scope of biomarkers significantly in the field of early renal injury.

Original languageEnglish
Pages (from-to)2893-2901
Number of pages9
JournalInternational Journal of Pharmaceutical Sciences and Research
Issue number7
Publication statusPublished - 01-01-2015

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science


Dive into the research topics of 'Early prediction of cisplatin nephrotoxicity in head and neck cancer patients - an evaluation with urinary biomarkers'. Together they form a unique fingerprint.

Cite this